Inventiva S.A. (EPA:IVA)
4.775
-0.005 (-0.10%)
May 14, 2026, 5:35 PM CET
Inventiva Revenue
In the year 2025, Inventiva had annual revenue of 4.48M EUR, down -51.26%. Inventiva had revenue of 29.00K in the half year ending December 31, 2025, a decrease of -99.81%.
Revenue
4.48M
Revenue Growth
-51.26%
P/S Ratio
146.69
Revenue / Employee
92.62K
Employees
77
Market Cap
991.80M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.48M | -4.72M | -51.26% |
| Dec 31, 2024 | 9.20M | -8.28M | -47.37% |
| Dec 31, 2023 | 17.48M | 5.30M | 43.50% |
| Dec 31, 2022 | 12.18M | 7.99M | 190.39% |
| Dec 31, 2021 | 4.19M | 3.82M | 1,027.42% |
| Dec 31, 2020 | 372.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Valneva SE | 174.66M |
| Genfit | 65.43M |
| Cellectis | 65.14M |
| Nanobiotix | 32.59M |
| MedinCell | 32.44M |
| Transgene | 7.21M |
| Sensorion | 5.81M |
| DBV Technologies | 4.97M |
Inventiva News
- 1 day ago - Inventiva to Present Abstracts at the EASL Congress 2026 - GlobeNewsWire
- 21 days ago - Inventiva CFO Jean Volatier to switch roles, Axel-Sven Malkomes to succeed - TheFly
- 21 days ago - Inventiva Strengthens Leadership Team Ahead of Expected Phase 3 Data Readout of Lanifibranor - GlobeNewsWire
- 4 weeks ago - Three new option listings and one option delisting on April 15th - TheFly
- 5 weeks ago - Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F - GlobeNewsWire
- 6 weeks ago - Inventiva price target lowered to $15 from $17 at Stifel - TheFly
- 6 weeks ago - Inventiva reports 2025 full year results and provides a business update - GlobeNewsWire
- 6 weeks ago - Inventiva management to meet with Piper Sandler - TheFly